Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: Importance of Pneumocystis pneumonia in Japan revealed by a multicenter study

Internal Medicine

Volumn 50, Issue 4, 2011, Pages 305-313

  Kameda, Hideto ^a   Tokuda, Hitoshi ^b   Sakai, Fumikazu ^c   Johkoh, Takeshi ^d   Mori, Shunsuke ^e   Yoshida, Yuji ^f   Takayanagi, Noboru ^g   Taki, Hirofumi ^h   Hasegawa, Yoshinori ⁱ   Hatta, Kazuhiro ^j   Yamanaka, Hisashi ^k   Dohi, Makoto ^l   Hashimoto, Shu ^m   Yamada, Hidehiro ⁿ   Kawai, Shinichi ^o   Takeuchi, Tsutomu ^p   Tateda, Kazuhiro ^o   Goto, Hajime ^q  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Social Health Insurance Central General Hospital   (Japan)

^c SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^d Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

^e Kumamoto Saishunsou National Hospital   (Japan)

^f NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^g Department of Respiratory Medicine Saitama Cardiovascular and Respiratory Center ^*  (Japan)

^h UNIVERSITY OF TOYAMA   (Japan)

ⁱ NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j TENRI HOSPITAL   (Japan)

^k TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^l UNIVERSITY OF TOKYO   (Japan)

^m NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^o TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^p SAITAMA UNIVERSITY   (Japan)

^q KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

D glucan; High resolution computed tomography; Pneumocystis pneumonia; Rheumatoid arthritis; Tumor necrosis factor inhibitor

Indexed keywords

ADALIMUMAB; BETA 1,3 GLUCAN; COTRIMOXAZOLE; ETANERCEPT; GLUCOCORTICOID; INFLIXIMAB; METHOTREXATE; TOCILIZUMAB; TUMOR NECROSIS FACTOR INHIBITOR;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BIOLOGICAL THERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; JAPAN; LOW DRUG DOSE; MALE; MICROSCOPY; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; RADIOLOGICAL PARAMETERS; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL PRODUCTS; FEMALE; HUMANS; JAPAN; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCYSTIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79951640108     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4508     Document Type: Article

References (25)

1. Smolen JS, Aletaha D, Bijlsma WJ, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69: 631-637, 2010.
2. Anaya JM, Diethelm L, Ortiz LA, et al. Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 24: 242-254, 1995.
3. Kim EJ, Collard HR, King Jr TE. Rheumatoid arthritis-associated interstitial lung disease. The relevance of histopathologic and ra-diographic pattern. Chest 136: 1397-1405, 2009.
4. Takeuchi T, Tatsuki Y, Nogami Y, et al. Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis 67: 189-194, 2008.
5. Koike T, Harigai M, Inokuma S, et al. Postmarketing surveillance of the safety profile and effectiveness of etanercept in Japan. J Rheumatol 36: 898-906, 2009.
6. Tokuda H, Sakai F, Yamada H, et al. Clinical and radiological features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and Pneumo-cystis pneumonia in acquired immunodeficiency syndrome: A multicenter study. Intern Med 47: 915-923, 2008.
7. Komano Y, Harigai M, Koike R, et al. Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: A retrospective review and case-control study of 21 patients. Arthritis Rheum 61: 305-312, 2009.
8. Kovacs JA, Hiemenz JW, Macher AM, et al. Pneumocystis carinii oneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 100: 663-671, 1984.
9. Limper AH, Offord KP, Smith TF, Martin WJ. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 140: 1204-1209, 1989.
10. Desmet S, van Wijngaerden E, Maertens J, et al. Serum (1-3)-β-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy. J Clin Microbiol 47: 3871-3874, 2009.
11. Iikuni N, Kitahama M, Ohta S, et al. Evaluation of Pneumocystis pneumonia infection risk factors in patients with connective tissue disease. Mod Rheumatol 16: 282-288, 2006.
12. Nakamura H, Tateyama M, Tasato D, et al. Clinical utility of serum β-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia. Intern Med 48: 195-202, 2009.
13. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med 353: 1685-1693, 2005.
14. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 369: 1553-1564, 2007.
15. Wakefield AE, Guiver L, Miller RF, Hopkin JM. DNA amplification on induced sputum samples for diagnosis of Pneumocystis carinii pneumonia. Lancet 337: 1378-1379, 1991.
16. Saito K, Nakayamada S, Nakano K, et al. Detection of Pneumo-cystis carinii by DNA amplification in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases. Rheumatol 43: 479-485, 2004.
17. Tasaka S, Hasegawa N, Kobayashi S, et al. Serum indicators for the diagnosis of Pneumocystis pneumonia. Chest 131: 1173-1180, 2007.
18. Tasaka S, Tokuda H, Sakai F, et al. Comparison of clinical and radiological features of Pneumocystis pneumonia between malignancy cases and acquired immunodeficiency syndrome cases: A multicenter study. Intern Med 49: 273-281, 2010.
19. Takeuchi T, Kameda H. The Japanese experience with biologic therapies for rheumatoid arthritis. Nat Rev Rheumatol 2010 [Epub ahead of print].
20. Oyama T, Kohno N, Yokoyama A, et al. Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measuring circulating levels of KL-6, a human MUC1 mucin. Lung 175: 379-385, 1997.
21. Crouch EC. Surfactant protein-D and pulmonary host defense. Respir Res 1: 93-108, 2000.
22. Johkoh T, Itoh H, Müller NL, et al. Crazy-paving appearance at thin-section CT: Spectrum of disease and pathologic findings. Radiology 211: 155-160, 1999.
23. Marty FM, Koo S, Bryar J, Baden LR. (1->3) beta-D glucan assay positivity in patients with Pneumocystis (carinii) jioveci pneumonia. Ann Intern Med 147: 70-72, 2007.
24. Nakamura H, Tateyama M, Tasato D, et al. Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia. Intern Med 48: 195-202, 2009.
25. Thomas CF Jr. Pneumocystis pneumonia. N Engl J Med 350: 2487-2498, 2004.